284 related articles for article (PubMed ID: 23606749)
1. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
[TBL] [Abstract][Full Text] [Related]
2. A novel regulatory pathway in granulosa cells, the LH/human chorionic gonadotropin-microRNA-125a-3p-Fyn pathway, is required for ovulation.
Grossman H; Chuderland D; Ninio-Many L; Hasky N; Kaplan-Kraicer R; Shalgi R
FASEB J; 2015 Aug; 29(8):3206-16. PubMed ID: 25921829
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of miR-125a-3p promotes fibroblast activation via Fyn/STAT3 pathway during silica-induced pulmonary fibrosis.
Xu Q; Liu Y; Pan H; Xu T; Li Y; Yuan J; Li P; Yao W; Yan W; Ni C
Toxicology; 2019 Feb; 414():57-67. PubMed ID: 30658076
[TBL] [Abstract][Full Text] [Related]
5. Regulation of GVBD in mouse oocytes by miR-125a-3p and Fyn kinase through modulation of actin filaments.
Grossman H; Har-Paz E; Gindi N; Levi M; Miller I; Nevo N; Galiani D; Dekel N; Shalgi R
Sci Rep; 2017 May; 7(1):2238. PubMed ID: 28533542
[TBL] [Abstract][Full Text] [Related]
6. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells.
Jiang L; Chang J; Zhang Q; Sun L; Qiu X
Cancer Invest; 2013 Oct; 31(8):538-44. PubMed ID: 24044511
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
11. miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway.
Liang L; Gao C; Li Y; Sun M; Xu J; Li H; Jia L; Zhao Y
Cell Death Dis; 2017 Aug; 8(8):e2968. PubMed ID: 28771224
[TBL] [Abstract][Full Text] [Related]
12. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
Qin X; Wan Y; Wang S; Xue M
Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.
Ninio-Many L; Grossman H; Levi M; Zilber S; Tsarfaty I; Shomron N; Tuvar A; Chuderland D; Stemmer SM; Ben-Aharon I; Shalgi R
Oncoscience; 2014; 1(4):250-261. PubMed ID: 25594017
[TBL] [Abstract][Full Text] [Related]
15. miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors.
Huang WK; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui WO
Exp Cell Res; 2018 Oct; 371(1):287-296. PubMed ID: 30149002
[TBL] [Abstract][Full Text] [Related]
16. HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.
Chu P; Xu L; Su H
J Physiol Biochem; 2019 Jun; 75(2):163-171. PubMed ID: 30863948
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
Lee M; Kim EJ; Jeon MJ
Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586
[TBL] [Abstract][Full Text] [Related]
19. NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn.
Liu Y; Zhu Y; Liu S; Liu J; Li X
Inflamm Res; 2021 Dec; 70(10-12):1113-1127. PubMed ID: 34591118
[TBL] [Abstract][Full Text] [Related]
20. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
